Rubler S, Dlugash J, Yuceoglu YZ, Kumral T, Branwood AW, Grishman A. New type of cardiomyopathy associated with diabetic glomerulosclerosis [J]. Am J Cardiol. 1972;30(6):595–602.
Article
CAS
PubMed
Google Scholar
Aneja A, Tang WH, Bansilal S, Garcia MJ, Farkouh ME. Diabetic cardiomyopathy: insights into pathogenesis, diagnostic challenges, and therapeutic options [J]. Am J Med. 2008;121(9):748–57.
Article
PubMed
Google Scholar
Fang ZY, Prins JB, Marwick TH. Diabetic cardiomyopathy: evidence, mechanisms, and therapeutic implications [J]. Endocr Rev. 2004;25(4):543–67.
Article
CAS
PubMed
Google Scholar
Fischer VW, Barner HB, Larose LS. Pathomorphologic aspects of muscular tissue in diabetes mellitus [J]. Hum Pathol. 1984;15(12):1127–36.
Article
CAS
PubMed
Google Scholar
Horiuchi K, Amizuka N, Takeshita S, Takamatsu H, Katsuura M, Ozawa H, et al. Identification and characterization of a novel protein, periostin, with restricted expression to periosteum and periodontal ligament and increased expression by transforming growth factor β [J]. J Bone Miner Res. 1999;14(7):1239–49.
Article
CAS
PubMed
Google Scholar
Kruzynska-Frejtag A, Machnicki M, Rogers R, Markwald RR, Conway SJ. Periostin (an osteoblast-specific factor) is expressed within the embryonic mouse heart during valve formation [J]. Mech Dev. 2001;103(1):183–8.
Article
CAS
PubMed
Google Scholar
Zhao S, Wu H, Xia W, Chen X, Zhu S, Zhang S, et al. Periostin expression is upregulated and associated with myocardial fibrosis in human failing hearts [J]. J Cardiol. 2014;63(5):373–8.
Article
PubMed
Google Scholar
Katsuragi N, Morishita R, Nakamura N, Ochiai T, Taniyama Y, Hasegawa Y, et al. Periostin as a novel factor responsible for ventricular dilation [J]. Circulation. 2004;110(13):1806–13.
Article
CAS
PubMed
Google Scholar
Stansfield WE, Andersen NM, Tang RH, Selzman CH. Periostin is a novel factor in cardiac remodeling after experimental and clinical unloading of the failing heart [J]. Ann Thorac Surg. 2009;88(6):1916–21.
Article
PubMed
PubMed Central
Google Scholar
Ladage D, Yaniz-Galende E, Rapti K, Ishikawa K, Tilemann L, Shapiro S, et al. Stimulating myocardial regeneration with periostin Peptide in large mammals improves function post-myocardial infarction but increases myocardial fibrosis [J]. PLoS One. 2013;8(5):e59656.
Article
CAS
PubMed
PubMed Central
Google Scholar
Iekushi K, Taniyama Y, Azuma J, Katsuragi N, Dosaka N, Sanada F, et al. Novel mechanisms of valsartan on the treatment of acute myocardial infarction through inhibition of the antiadhesion molecule periostin [J]. Hypertension. 2007;49(6):1409–14.
Article
CAS
PubMed
Google Scholar
Conway SJ, Molkentin JD. Periostin as a heterofunctional regulator of cardiac development and disease [J]. Curr Genomics. 2008;9(8):548.
Article
CAS
PubMed
PubMed Central
Google Scholar
Norris RA, Moreno-Rodriguez R, Hoffman S, Markwald RR. The many facets of the matricelluar protein periostin during cardiac development, remodeling, and pathophysiology [J]. Journal of cell communication and signaling. 2009;3(3-4):275–86.
Article
PubMed
PubMed Central
Google Scholar
Snider P, Standley KN, Wang J, Azhar M, Doetschman T, Conway SJ. Origin of cardiac fibroblasts and the role of periostin [J]. Circ Res. 2009;105(10):934–47.
Article
CAS
PubMed
PubMed Central
Google Scholar
Zou P, Wu LL, Wu D, Fan D, Cui XB, Zhou Y, et al. High glucose increases periostin expression and the related signal pathway in adult rat cardiac fibroblasts [J]. Sheng Li Xue Bao. 2010;62(3):247–54.
CAS
PubMed
Google Scholar
Yang ZH, Peng XD. Effects of valsartan on diabetic cardiomyopathy in rats with type 2 diabetes mellitus [J]. Chin Med J (Engl). 2010;123(24):3640–3.
CAS
Google Scholar
Fiordaliso F, Li B, Latini R, Sonnenblick EH, Anversa P, Leri A, et al. Myocyte death in streptozotocin-induced diabetes in rats in angiotensin II-dependent [J]. Lab Invest. 2000;80:513–27.
Article
CAS
PubMed
Google Scholar
Li L, Fan D, Wang C, Wang JY, Cui XB, Wu D, et al. Angiotensin II increases periostin expression via Ras/p38 MAPK/CREB and ERK1/2/TGF-β1 pathways in cardiac fibroblasts [J]. Cardiovasc Res. 2011;91(1):80–9.
Article
CAS
PubMed
Google Scholar
Crawford J1, Nygard K, Gan BS, O'Gorman DB. Periostin induces fibroblast proliferation and myofibroblast persistence in hypertrophic scarring [J]. Exp Dermatol. 2014 Nov 24. doi:10.1111/exd.12601.
Hai-feng ZHANG, Feng WANG, Hong Sun, Mingming Xue. Effects of Pioglitazone on AngII、SOD、NO in Cardiac Hypertrophic Rats [J]. Inner Mongolia Med J. 2013;45(9):1031–3.
Google Scholar
Westermann D, Walther T, Savvatis K, Escher F, Sobirey M, Riad A, et al. Gene deletion of the kinin receptor B1 attenuates cardiac inflammation and fibrosis during the development of experimental diabetic cardiomyopathy [J]. Diabetes. 2009;58(6):1373–81.
Article
PubMed
PubMed Central
Google Scholar
Porter KE, Turner NA. Cardiac fibroblasts: at the heart of myocardial remodeling [J]. Pharmacol Ther. 2009;123(2):255–78.
Article
CAS
PubMed
Google Scholar
Murarka S, Movahed MR. Diabetic cardiomyopathy [J]. J Card Fail. 2010;16(12):971–9.
Article
PubMed
Google Scholar
TSCHÖPE C, Walther T, KÖNIGER J, Spillmann F, Westermann D, Escher F, et al. Prevention of cardiac fibrosis and left ventricular dysfunction in diabetic cardiomyopathy in rats by transgenic expression of the human tissue kallikrein gene [J]. FASEB J. 2004;18(7):828–35.
Article
PubMed
Google Scholar
Dai HY, Guo XG, Ge ZM, Li ZH, Yu XJ, Tang MX, et al. Elevated expression of urotensin II and its receptor in diabetic cardiomyopathy [J]. J Diabetes Complications. 2008;22(2):137–43.
Article
PubMed
Google Scholar
Oka T, Xu J, Kaiser RA, Melendez J, Hambleton M, Sargent MA, et al. Genetic manipulation of periostin expression reveals a role in cardiac hypertrophy and ventricular remodeling [J]. Circ Res. 2007;101(3):313–21.
Article
CAS
PubMed
PubMed Central
Google Scholar
Norris RA, Borg TK, Butcher JT, Baudino TA, Banerjee I, Markwald RR. Neonatal and adult cardiovascular pathophysiological remodeling and repair: developmental role of periostin [J]. Ann N Y Acad Sci. 2008;1123:30–40.
Article
CAS
PubMed
Google Scholar
Crawford J, Nygard K, Gan BS, O'Gorman DB. Periostin induces fibroblast proliferation and myofibroblast persistence in hypertrophic scarring [J]. Exp Dermatol. 2014 Nov 24. doi:10.1111/exd.12601.
Ren J, Davidoff AJ. Diabetes rapidly induces contractile dysfunctionsin isolated ventricular myocytes [J]. Am J Physiol Heart Circ Physiol. 1997;272:148–58.
Google Scholar
Carley AN, DL S s. Fatty acid metabolism is enhanced in type 2 diabetic hearts [J]. Biochim Biophys Acta JT-Biochimicaet Biophysica Acta. 2005;1734(2):112.
Article
CAS
Google Scholar
Feng Z, Qiutang Z, Bingong L, Shuguo L. The alterations of peroxisome proliferator-activated receptor alpha ( PPARα) and free fatty acids in STZ-induced diabetic cardiomyopathy rats [J]. Central China Medical Journal. 2007;31(5):364–6.
Google Scholar
Khatter JC, Sadri P, Zhang M, Hoeschen RJ. Myocardial angiotensin II (Ang II) receptors in diabetic rats [J]. Ann N Y Acad Sci. 1996;793:466–72.
Article
CAS
PubMed
Google Scholar
Sechi LA, Griffin CA, Schambelan M. The cardiac renin–angiotensin system in STZ-induced diabetes. Diabetes [J]. 1994;43:1180–4.
Article
CAS
Google Scholar
Kim S, Wanibuchi H, Hamaguchi A, Miura K, Yamanaka S, Iwao H. Angiotensin blockade improves cardiac and renal complications of type II diabetic rats [J]. Hypertension. 1997;30:1054–61.
Article
CAS
PubMed
Google Scholar
Chan P, Wong KL, Liu IM, Tzeng TF, Yang TL, Cheng JT. Anti-hyperglycemic action of angiotensin II receptor antagonist, valsartan, in streptozotocin-induced diabetic rats [J]. J Hypertens. 2003;21(4):761–9.
Article
CAS
PubMed
Google Scholar